ESTA - Establishment Labs Holdings Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
23.16
+0.08 (+0.35%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close23.08
Open23.00
Bid0.00 x 900
Ask0.00 x 2200
Day's Range22.50 - 23.17
52 Week Range20.05 - 30.71
Volume61,209
Avg. Volume66,879
Market Cap472.677M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.35
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est37.40
Trade prices are not sourced from all markets
  • GlobeNewswirelast month

    Establishment Labs Announces Additional Financing and Improved Terms with Amendment to Existing Credit Agreement

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into an amendment to its existing credit agreement (the “Credit Agreement”) with affiliates of Madryn Asset Management, LP, (“Madryn”) effective June 17, 2019. The amended terms of the Credit Agreement, which was originally entered into on August 24, 2017, provides Establishment Labs with up to $25 million in new borrowing capacity from Madryn to increase the company’s financial flexibility.  The amended Credit Agreement extends the maturity date on all loans to a full repayment on September 30, 2025, reduces the interest rate on all loans from LIBOR plus 11% per annum down to LIBOR plus 8% per annum, and modifies certain other terms and provisions.

  • GlobeNewswire2 months ago

    Establishment Labs Holdings Inc. and Allergan Sales, LLC Extend Distribution and Supply Agreement for MotivaImagine® Insertion Sleeve

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has reached an agreement with Allergan Sales, LLC to extend an agreement to import, sell and distribute the MotivaImagine® Insertion Sleeve across the agreed upon countries as part of the MotivaImagine® suite of products for breast surgery. Using best-in-class technology, the MotivaImagine® Insertion Sleeve is a surgical tool that assists plastic surgeons with a no touch effortless implant insertion process with Motiva Implants®. It is one of the components of the MotivaImagine® ecosystem, partnering Establishment Labs with plastic surgery centers in more than 70 countries worldwide.

  • Business Wire2 months ago

    Glancy Prongay & Murray LLP Announces Investigation on Behalf of Establishment Labs Holdings Inc. Investors (ESTA)

    Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) investors concerning the Company and its officers’ possible violations of federal securities laws. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. On April 10, 2019, Seeking Alpha published an article, alleging in relation to the Company’s accounting, “near-zero product return allowance, extremely high levels of inventory, several going concern clauses, a peripatetic CEO and a physically detached CFO.” In addition to these claims, the article also alleged that the Company provided inaccurate information to both the SEC and investors.

  • GlobeNewswire2 months ago

    Establishment Labs to Present at Jefferies 2019 Healthcare Conference

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that Chief Executive Officer Juan José Chacón-Quirós will be presenting at the Jefferies Healthcare Conference on June 4, 2019 at 11:30 a.m. Eastern Time. Establishment Labs Holdings Inc. (ESTA) is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in over 70 countries through exclusive distributors or the Company’s direct salesforce.

  • Business Wire2 months ago

    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Establishment Labs Holdings Inc. Investors (ESTA)

    Law Offices of Howard G. Smith announces an investigation on behalf of Establishment Labs Holdings Inc.  investors concerning the Company and its officers’ possible violations of federal securities laws.

  • PR Newswire2 months ago

    ESTABLISHMENT LABS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Establishment Labs Holdings Inc. To Contact The Firm

    NEW YORK , May 17, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Establishment Labs Holdings Inc. ("Establishment Labs" ...

  • Business Wire2 months ago

    EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Establishment Labs Holdings Inc.; Investors are Encouraged to Contact the Firm

    Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. resulting from allegations that Establishment Labs may have issued materially misleading business information to the investing public.

  • Establishment Labs Holdings Inc (ESTA) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Establishment Labs Holdings Inc (ESTA) Q1 2019 Earnings Call Transcript

    ESTA earnings call for the period ending March 31, 2019.

  • GlobeNewswire2 months ago

    Establishment Labs Reports First Quarter 2019 Financial Results

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2019. Continued revenue growth driven by the ongoing strong adoption of Motiva Implants® across addressable markets. “We are pleased to report a record quarter of sales as we continued to build upon the momentum achieved in 2018,” said Juan José Chacón-Quirós, Chief Executive Officer of Establishment Labs.

  • Were Hedge Funds Right About Dumping Establishment Labs Holdings Inc. (ESTA)
    Insider Monkey2 months ago

    Were Hedge Funds Right About Dumping Establishment Labs Holdings Inc. (ESTA)

    Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock. S&P 500 Index ETF (SPY) lost 13.5% in the fourth quarter. Seven out of 11 industry groups in the S&P 500 Index were down more than 20% from their 52-week […]

  • GlobeNewswire3 months ago

    Establishment Labs to Present at UBS Global Healthcare Conference

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will be presenting at the UBS Global Healthcare Conference on May 20, 2019 at 1:30 p.m. Eastern Time. Establishment Labs Holdings Inc. (ESTA) is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently sold in over 60 countries through exclusive distributors or the Company’s direct salesforce.

  • Establishment Labs Holdings Inc. (NASDAQ:ESTA): What's The Analyst Consensus Outlook?
    Simply Wall St.3 months ago

    Establishment Labs Holdings Inc. (NASDAQ:ESTA): What's The Analyst Consensus Outlook?

    The latest earnings release Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) announced in December 2018 confirmed that losses became smaller relative to the prior year's level - great news for invest...

  • GlobeNewswire3 months ago

    Establishment Labs to Announce First Quarter 2019 Financial Results

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the first quarter 2019, ended March 31, 2019, before market open on Wednesday, May 15, 2019. Establishment Labs will host a webcast the same day at 8:30 a.m. Eastern Time to discuss the results. The webcast will be available for 30 days following the call on the Investor Relations section of the Company's website at www.establishmentlabs.com.

  • PR Newswire3 months ago

    Lifshitz & Miller LLP Announces Investigation of Anadarko Petroleum Corporation, Duluth Holdings, Inc., Establishment Labs Holdings Inc., Flex Ltd., Global Brass and Copper Holdings, Inc., Indivior PLC, Papa Murphy's Holdings, Inc., and Zogenix, Inc.

    NEW YORK , April 17, 2019 /PRNewswire/ -- Anadarko Petroleum Corporation (APC) Lifshitz & Miller  announces investigation into possible breach of fiduciary duties in connection with the proposed sale of ...

  • GlobeNewswire3 months ago

    ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Establishment Labs Holdings Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ: ESTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

  • Business Wire3 months ago

    INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Establishment Labs Holdings Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ: ESTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

  • GlobeNewswire3 months ago

    Bragar Eagel & Squire, P.C. is Investigating Establishment Labs Holdings Inc. (ESTA) on Behalf of Stockholders and Encourages ESTA Investors to Contact the Firm

    NEW YORK, April 10, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against Establishment Labs Holdings Inc. (NASDAQ: ESTA).  Our investigation.

  • Business Wire3 months ago

    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Establishment Labs Holdings Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Establishment Labs Holdings Inc. (“Establishment Labs” or “the Company”) (NASDAQ: ESTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

  • Business Wire3 months ago

    EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Establishment Labs Holdings Inc. – ESTA

    Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Establishment Labs Holdings Inc. resulting from allegations that Establishment Labs may have issued materially misleading business information to the investing public.

  • GlobeNewswire3 months ago

    Establishment Labs Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

    BOSTON, April 10, 2019 -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Establishment.

  • Establishment Labs Holdings Inc (ESTA) Q4 2018 Earnings Conference Call Transcript
    Motley Fool4 months ago

    Establishment Labs Holdings Inc (ESTA) Q4 2018 Earnings Conference Call Transcript

    ESTA earnings call for the period ending December 31, 2018.

  • GlobeNewswire4 months ago

    Establishment Labs Reports Fourth Quarter and Full Year 2018 Financial Results

    NEW YORK, March 20, 2019 -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and.

  • GlobeNewswire5 months ago

    Establishment Labs to Present at the Cowen 39th Annual Health Care Conference

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in a fireside chat presentation at the Cowen 39th Annual Health Care Conference on Wednesday, March 13, 2019 at 9:20 a.m. Eastern Time. The fireside chat will be webcast live and may be accessed on the investor relations portion of the Company’s website at www.establishmentlabs.com, where it will be archived. Establishment Labs Holdings Inc. (ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform.

  • GlobeNewswire5 months ago

    Establishment Labs to Announce Fourth Quarter and Full Year 2018 Financial Results

    Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the fourth quarter and full year 2018, ended December 31, 2018, after market close on Wednesday, March 20, 2019. Establishment Labs will host a webcast the same day at 4:30 p.m. Eastern Time to discuss the results.   The conference call can be accessed by dialing (877) 376-9925 (U.S. and Canada) or (629) 228-0732 (international), and using the conference ID: 9089791. In addition, the webcast will be available on the Investor Relations section of the Company's website at www.establishmentlabs.com.

  • What Investors Should Know About Establishment Labs Holdings Inc.’s (NASDAQ:ESTA) Financial Strength
    Simply Wall St.6 months ago

    What Investors Should Know About Establishment Labs Holdings Inc.’s (NASDAQ:ESTA) Financial Strength

    Investors are always looking for growth in small-cap stocks like Establishment Labs Holdings Inc. (NASDAQ:ESTA), with a market cap of US$524m. However, an important fact which most ignore is: how Read More...